Skip to content


BMC Pediatrics

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Exercise reduces body fat and improves insulin sensitivity and pancreatic β-cell function in overweight and obese male Taiwanese adolescents

BMC PediatricsBMC series – open, inclusive and trusted201818:80

Received: 23 December 2016

Accepted: 29 January 2018

Published: 22 February 2018



Improvements in insulin resistance and pancreatic β-cell function have been shown following exercise in adults with obesity; however, few adolescent-based studies have been conducted. This study examined the impact of exercise training on body fat and insulin sensitivity and secretion in overweight and obese adolescents.


The effects of a 12-week exercise program on the parameters of adiposity and glucose homeostasis were investigated in 47 overweight and obese male adolescents.


After the exercise training program, body weight, body mass index, waist circumference, and body fat were significantly decreased (P < 0.001). Improvements in insulin sensitivity (HOMA-IR: 1.40 vs. 0.86, P < 0.001) and the disposition index (5.84 vs. 12.77, P < 0.001) were also observed. Compared to baseline, oral glucose tolerance tests showed reduced glucose and insulin levels at all time points following the exercise training (all P < 0.001). Subgroup analysis of overweight and obese adolescents with abnormal glucose tolerance revealed that there was no difference in plasma glucose levels as compared to the lean group.


A 12-week exercise training is effective in reducing body fat and improving insulin sensitivity and secretion. In addition, the benefits of the exercise intervention were even experienced by those with impaired glucose tolerance.


β-cell functionExerciseInsulin resistanceObesityType 2 diabetes


Type 2 diabetes mellitus (T2DM) is now increasingly diagnosed in children and adolescents [13], which is likely due to the increased prevalence of childhood obesity. High childhood body mass index (BMI) is positively associated with adult coronary heart disease, diabetes and a range of cancers. β-cell dysfunction and insulin resistance are key elements in the pathogenesis of T2DM in both youth and adults patients [4, 5]. It is postulated that in the development of T2DM in youth, an early defect in first-phase insulin response, is followed by defects in second-phase response with development of overt diabetes [6, 7], and these deteriorations occur in the context of a decline in insulin sensitivity. Thus, given its high prevalence and link to chronic disease, early effective interventions for the treatment of childhood obesity and its metabolic abnormalities are urgently needed.

The benefits of exercise for improving glucose homeostasis and insulin resistance are well-established for adults with overweight and obesity, and amelioration of the insulin sensitivity and β-cell function following exercise training is independent of reductions in body weight or adipose tissue as well as improved body lean mass. For example, large improvements in insulin resistance occur after exercise and/or caloric restriction in obese adults with and without diabetes [8, 9]. In addition, physical activities of moderate intensity can substantially reduce the risk of T2DM [10]. Furthermore, previous studies have also highlighted the beneficial effects of lifestyle interventions on insulin secretion and β-cell function in adults with obesity [1113]. Moreover, a recent meta-analysis that included nine randomized controlled trials reported improvements in insulin resistance markers in youth with obesity with aerobic exercise programs lasting > 12 weeks [14]. In lean male adolescents, we have previously shown that a 12-week exercise program reduced many anthropomorphic measures and blood pressure while increasing the levels of anti-inflammatory markers, such as adiponectin, interleukin-6 (IL-6), and C-reactive protein [15]. In addition to improved β-cell function, the same exercise intervention also improved insulin sensitivity with similar reductions in anthropomorphic measures in male adolescents with obesity [16]. However, to our knowledge, only one study has examined the effects of exercise on β-cell function in adolescents [17].

We sought to test the hypothesis that exercise training would be associated with reductions in body fat and improvements in insulin sensitivity and secretion in overweight and obese Taiwanese male adolescents. In the present study, the effects of a 12-week exercise program on the parameters of adiposity and glucose homeostasis were investigated in overweight and obese adolescent boys.


Study participants

Participants of this study included 108 male adolescents (15–17 year) from the Army Academy of Taiwan. Participants were classified as lean, overweight, or obese by comparing their BMI with age- and gender-appropriate cut-off values developed by the Department of Health of Taiwan [18]. Participants classified as overweight or obese were included in the overweight/obese group for analysis. Participants’ pubertal development was ≥IV, as assessed according to Tanner criteria [19] by a physician and/or a trained nurse practitioner. Exclusion criteria included the following: history of known heart disease, diabetes, renal disease, secondary obesity, or underlying genetic syndromes. All subjects had not participated in any weight loss program 6 months prior to the initiation of the present study, were not taking any medication, and were nonsmokers. The Institution Review Board of the Taipei Veterans General Hospital approved this study. Written informed consent was obtained after explaining the study procedures and protocol to the participants and their parents or legal guardians.

Experimental control and pre-tests

All subjects were asked to record a baseline diet log before initiation of the study. Although education on the principles of a healthy diet was given and the participants were encouraged to decrease their food intake or at least consume a weight-maintaining high-carbohydrate diet, they chose their own food throughout the study.

All of the participants were also asked to refrain from vigorous exercise 3 days before the baseline anthropomorphic measurements. In addition to baseline measurements, all anthropomorphic measurements were taken again 7 days after completion of the 12-week exercise regimen in participants of the overweight/obese group. Anthropomorphic measurements were done between 8:00 and 8:30 AM following a 12-h fast; however, all participants were permitted to drink water. Each participant emptied his bladder and then height, weight and waist circumference (WC) were measured by trained staff. BMI was calculated as weight (in kilograms) divided by squared height (in square meters). The body fat percentage (BFP) and body fat mass (BFM) were measured using a bioelectrical body composition analyzer (Quantum X; RJL System, Clinton Township, MI, USA). An electrocardiogram was used to evaluate cardiac function in all subjects. Blood samples were taken from the antecubital vein of the arm at 9:00 AM. A 2-h oral glucose tolerance test (OGTT) was then performed according to a standardized procedure [20].

Exercise regimen

Each participant in the overweight/obese group exercised five times per week, Monday through Friday, for 12 weeks. As part of the routine physical education training for the recruits, each 40-min session included a 10-min warm-up/flexibility period, a 25-min physical training period, and a 5-min cool-down period. During the warm-up/flexibility period, participants performed push-up and sit-up exercises followed by 5 min of stretching. In the physical training period, participants were asked to run moderately. This activity involved movement of the whole body to ensure maximum caloric expenditure. A high-intensity phase of physical training occurred in the last 5 min when participants were encouraged to run to the limit of their tolerance. In the cool-down period, the participants walked slowly for approximately 5 min. Throughout the exercise session, an experienced physical education instructor supervised all participants. Each week, a physician as well as participants’ legal guardians monitored one of the five sessions. In addition, all of the participants completed each session in the 12-week program, and compliance was 100%.


In the overweight/obese group, OGTT was performed 3 days prior to the exercise training period for the baseline assessments and 7 days following the end of the training program. Participants were asked to consume a weight-maintaining diet containing 250 g of carbohydrate per day and refrain from vigorous physical activity 3 days before the OGTT. An antecubital vein was cannulated for blood sampling at 8:50 AM. Baseline fasting blood samples were obtained at 9:00 AM after 10 min of rest. OGTT was performed with the administration of 75 g of anhydrate glucose in 300 mL of water within 5 min. Blood samples were drawn every 30 min for 2 h to evaluate plasma glucose and serum insulin levels.

The overweight/obese adolescents with impaired glucose tolerance (IGT) had impaired fasting glucose tolerance or glucose tolerance or both, as defined by American Diabetes Association recommendations [20].

Laboratory measurements

Venous blood samples were taken after a 12-h fast for the measurement of fasting plasma glucose (FPG) and fasting serum insulin (FSI). After centrifugation, all sera were kept on ice immediately and stored at − 80 °C within 1 h. Plasma glucose was measured using the glucose oxidase method (Model 2300 STAT; Yellow Springs Instrument, Yellow Springs, OH, USA). Serum insulin was determined by a microparticle enzyme immunoassay using the AxSYM system from Abbott Diagnostics (Abbott Laboratories, Dainabot, Tokyo, Japan).

Homeostasis model assessment of insulin resistance (HOMA-IR) was calculated as follows: FSI × FPG/22.5, where insulin is expressed in μIU per mL and glucose in mmol/L) [21]. OGTT-derived parameters were used to evaluate insulin secretion [22]. Early-phase insulin release was calculated as the ratio of the change in insulin levels to the change in glucose levels from 0 to 30 min (∆I0–30/∆G0–30). Total insulin release was calculated using the ratio of insulin area under the curve (AUC) and glucose AUC during 0–120 min of the OGTT (InsAUC120/GluAUC120). AUC was calculated by the trapezoidal method from 0 to 120 min. Since the insulin response of β-cells to glucose is modulated by the severity of insulin resistance, the disposition index (DI), which adjusts insulin secretion for insulin resistance, was used to measure β-cell function [23] and was calculated as follows: (∆I0–30/∆G0–30)/HOMA-IR [24].

Statistical analysis

Continuous data (i.e., height, weight, BMI, WC, hip circumference and waist-to-hip ratio) with normal distribution were expressed as mean ± standard deviation; data with non-normal distribution were expressed as median (with an interquartile range between P25 and P75). Differences in baseline characteristics and HOMA-IR between the lean group and group with obesity were examined by independent t-tests or Mann-Whitney U tests for parameters with normal or skewed distributions. Analysis of variance (ANOVA) was also performed to test differences in plasma glucose between the lean group and subgroups of the adolescents with obesity (i.e., those with normal or abnormal glucose tolerance). Bonferroni correction was carried out after a significant difference was revealed by ANOVA. The post-training changes were examined by paired t-tests for participants with obesity. A P-value < 0.05 was considered statistically significant. An adjusted alpha level of 0.017 (0.05/3) was applied when the Bonferroni correction was required. All statistical statistics were two-sided and performed using SPSS statistical software (version 22.0, IBM Corp., Armonk, NY).


Exercise improved anthropomorphic parameters with exercise

The anthropometric parameters of the study participants, including 61 lean participants and 47 overweight/obese participants, are shown in Table 1. Before training, the height, weight, BMI, WC, hip circumference, BFP, BFM, and lean body mass of overweight/obese participants were significantly greater than those in the lean group (all P ≤ 0.037). These parameters remained greater in the overweight/obese group following training; however, significant improvements in all aforementioned parameters were observed in the overweight/obese group (all P ≤ 0.002). Specifically, their BMI, BFP and BFM decreased by 4.5, 28.2, and 30.3%, respectively. Moreover, the Matsuda/Defronzo index significantly increased in the overweight/obese participants following the exercise training (P < 0.001).
Table 1

Comparison of anthropometric parameters between overweight/obese male adolescents at baseline and after a 12-week exercise program with lean adolescents (n = 108)


Lean n = 61)

Overweight/Obese before training (n = 47)

P baseline

Overweight/Obese after training (n = 47)

P after

P paired

Height (cm)

170.62 ± 5.79

172.61 ± 3.99


Weight (kg)

61.94 ± 5.93

83.21 ± 6.12

< 0.001

78.77 ± 7.6

< 0.001

< 0.001

BMI (kg/m2)

21.24 ± 1.31

27.9 ± 1.39

< 0.001

26.66 ± 2.12

< 0.001

< 0.001

Waist line (cm)

73.26 ± 4.53

90.61 ± 5.12

< 0.001

87.13 ± 5.36

< 0.001

< 0.001

Hip circumference (cm)

91.32 ± 3.65

105.78 ± 3.64

< 0.001

104.26 ± 4.54

< 0.001


W/H ratio

0.80 ± 0.03

0.86 ± 0.04

< 0.001

0.84 ± 0.03

< 0.001

< 0.001

BFP (%)

14.41 ± 4.36

25.14 ± 3.45

< 0.001

18.04 ± 5.06

< 0.001

< 0.001

BFM (kg)

9.06 ± 3.16

20.62 ± 3.95

< 0.001

14.37 ± 4.70

< 0.001

< 0.001

Lean mass (kg)

53.53 ± 4.74

62.36 ± 5.04

< 0.001

64.21 ± 5.52

< 0.001


Fasting plasma glucose (mmol/L)

4.37 ± 0.42

5.00 ± 0.41

< 0.001

4.58 ± 0.38


< 0.001

Fasting serum insulin (μIU/mL)

4.51 ± 2.15

7.58 ± 4.17

< 0.001

4.70 ± 2.32


< 0.001

Homeostasis model assessment of insulin resistance

0.74 (0.62, 1.08)

1.40 (0.93, 2.31)

< 0.001

0.86 (0.58, 1.36)


< 0.001

Total insulin release (InsAUC0–120) (μIU/mM)

4.65 (3.03, 6.01)

3.57 (2.84, 4.52)

< 0.001

Early-phase insulin release (μIU/mM)

8.62 (5.24, 12.25)

11.40 (6.76, 16.27)


Disposition index

5.84 (2.84, 9.67)

12.77 (7.27, 23.23)

< 0.001

Matsuda/Defronzo index

6.91 (1.87, 14.25)

12.55 (3.17, 22.54)


< 0.001

BMI body mass index, BFP body fat percentage, BFM body fat mass; Pbaseline = P-values for group difference at baseline; Pafter = P-values for group difference after training; Ppaired = P-values of post-training changes in the overweight/obese group

All other data are shown as mean ± standard deviation

Bold values indicate a statistical difference between the two groups or between pre- and post-training, P < 0.05

Dash denotes ‘not applicable’

Improved glucose homeostasis following a 12-week exercise program

As shown in Table 1, differences in FPG, FSI, and HOMA-IR were noted between the two groups at baseline. Specifically, the overweight/obese group had higher FPG, FSI and HOMA-IR (all P < 0.001). After the training program, significant decreases in FPG, FSI, HOMA-IR, and total insulin release as well as increases in early-phase insulin release and DI were observed in the overweight/obese group (all P ≤ 0.008).

Post-OGTT changes in plasma glucose and serum insulin in the overweight/obese group are illustrated in Fig. 1. Both parameters were significantly diminished after the training (Fig. 1a & b).
Fig. 1

Effects of a 12-week exercise program on glucose and insulin levels in overweight/obese adolescents. Glucose (a) and insulin (b) levels obtained with an oral glucose tolerance test in 47 adolescents with obesity at baseline and after a 12-week exercise program. Data are shown as mean ± standard deviation. Pre- and post-training area under curves (AUCs) of plasma glucose and serum insulin were compared using paired t-tests for each group, and significant changes were found after the training (P < 0.001 for both plasma glucose and serum insulin)

The overweight/obese group was further divided into two subgroups based on their pre-training glucose homeostasis status, including 36 with normal glucose tolerance (NGT) and 11 with impaired glucose tolerance (IGT; Table 2). As shown in Table 2, both groups of adolescents had common anthropometric measures, including weight, BMI, WC, hip circumference, W/H ratio, and lean body mass. Moreover, no differences in total cholesterol, low-density lipoprotein-cholesterol, high-density lipoprotein–cholesterol, alanine aminotransferase (U/L), and uric acid were noted (data not shown).
Table 2

Anthropometric parameters in overweight/obese adolescents and normal or impaired glucose tolerance before training (n = 47)


NGT (n = 36)

IGT (N = 11)


Height (cm)

172.44 ± 3.88

173.18 ± 4.47


Weight (kg)

82.71 ± 4.98

84.86 ± 9.02


Body mass index (kg/m2)

27.8 ± 1.15

28.24 ± 2.04


Waist circumference (cm)

90.43 ± 4.23

91.23 ± 7.56


Hip circumference (cm)

105.29 ± 3.28

107.36 ± 4.43


W/H ratio

0.86 ± 0.04

0.85 ± 0.05


Body fat percentage (%)

24.00 (22.00, 26.00)

28.00 (26.00, 29.00)


Body fat mass (kg)

19.70 (18.00, 22.40)

22.55 (20.00, 27.10)


Lean mass (kg)

62.41 (50.54, 72.51)

62.13 (53.38–72.88)


Height, weight, body mass index, waist, hip and W/H ratio are shown as mean ± standard deviation, and the other parameters are expressed as median (interquartile range)

Bold values indicate a statistical difference between the two groups, P < 0.05

Although overweight/obese patients in the IGT group had higher BFP and BFM before training, the values in the IGT group reduced to the level similar to those in the NGT group (P = 0.066 and P = 0.090, respectively) after the exercise program (data not shown). In terms of indices of homeostasis, the IGT group had higher baseline FPG, FSI, HOMA-IR, total insulin release, and lower DI than the NGT group (all P ≤ 0.039; Table 3). This group also had lower Matsuda/Defronzo index score (P < 0.001) After the exercise training program, significant reductions in FPG, FSI, HOMA-IR, and total insulin release (all P ≤ 0.034), along with an increase in the DI (both P ≤ 0.011) were observed in both groups (Table 3). In the NGT group, the level of insulin release was also significantly increased (P = 0.025). Compared with the NGT group, patients in the IGT group had greater changes in FPG, FSI, HOMA-IR, and total insulin release, and the pre-training differences between two groups were no longer significant. No differences in the Matsuda/Defronzo index values between the NGT and IGT groups were observed following the exercise program (Table 3).
Table 3

Homeostasis parameters in overweight/obese adolescents and normal or impaired glucose tolerance after training (n = 47)


NGT before training (n = 36)

IGT before training (n = 11)

P before

NGT after training (n = 36)

IGT after training (n = 11)

P after

Fasting plasma glucose (mmol/L)

4.83 (4.61, 5.14)

5.39 (5.11, 5.72)

< 0.001

4.55 (4.4, 4.77)

4.61 (4.47, 4.96)


Fasting serum insulin (μIU/mL)

5.6 (4.4, 8.9)

9.15 (8.1, 12.1)


4.5 (3, 6.5)

4.2 (2.8, 4.70)



1.29 (0.88, 1.92)

2.28 (1.84, 2.9)


0.87 (0.59, 1.36)

0.86 (0.55, 0.96)


Total insulin release (μIU/mM)

4.04(3.01, 5.55)

6.52 (4.39, 9.11)


3.57 (3, 4.36)

3.95(2.58, 6.06)


Early-phase insulin release (μIU/mM)

8.49(5.44, 11.72)

10.22 (1.55, 19.77)


11.16 (6.46, 15.53)

12.83(7.34, 20.17)


Disposition index

6.71(3.43, 12.79)

3.19 (0.95, 6.82)


12.46 (6.11, 23.52)

14.90(9.93, 22.70)


Matsuda/Defronzo index

7.58 (2.76–14.58)

4.08 (1.87–7.32)

< 0.001

12.97 (5.32, 22.54)

10.75 (3.17, 18.00)


Change from baseline


P group

 Fasting plasma glucose (mmol/L)

−0.40 (−0.53, −0.07)*

−0.64 (− 0.94, − 0.32)*


 Fasting serum insulin (μIU/mL)

−1.50 (−3.00, 0.00)*

−6.15 (−8.20, −2.80)*



− 0.48 (− 0.76, 0.02)*

−1.50 (− 2.01, − 0.68)*


 Total insulin release (μIU/mM)

− 0.49 (− 1.67, 0.43)*

−1.92 (− 3.21, − 0.99)*


 Early-phase insulin release (μIU/mM)

2.25 (− 0.22, 6.30)*

2.12 (1.33, 14.90)


 Disposition index

5.29 (− 0.83, 15.18)*

13.07 (4.11, 22.41)*


 Matsuda/Defronzo index


5.39 (−5.72, 18.71)*

6.67 (0.53, 13.50)*


HOMA-IR homeostasis model assessment of insulin resistance; Pbefore = P-values for group differences before training; Pafter = P-values for group differences after training; Pgroup = P-values for group differences in changes from baseline

Data are presented as median (interquartile range)

Dash indicate data are unavailable

* denotes significant change after training

Bold values indicate a statistical difference between the two groups or a significant change after training, P < 0.05

Changes in plasma glucose levels in the IGT and NGT subgroups of overweight/obese adolescents are shown in Fig. 2. Before training, the plasma glucose level was significantly higher in both NGT and IGT groups than in the lean group (P < 0.001). However, after training, there was no difference in plasma glucose among the three groups.
Fig. 2

Change in plasma glucose levels in a 2-h oral glucose tolerance test (n = 61 in the lean group marked in black diamond, n = 36 in the NGT group marked in white circle for pre-training and black circle for post-training, and n = 11 in the IGT group marked in white square for pre-training and black square for post-training). Mean ± standard deviation is shown for plasma glucose. Area under curve (AUC) of plasma glucose was used for comparisons among the groups. Analysis of variance was implemented for testing the difference in plasma glucose among the three groups (i.e. the lean, the IGT and NGT groups), and paired tests were employed for testing post-training differences for the two subgroups. * significant change after training. a significant difference between either the IGT or NGT group and the lean group


Given the increase in childhood obesity and associated metabolic abnormalities and their link with chronic disease in adults, interventions are urgently needed. The present study evaluated the effects of exercise training without diet control in male adolescents who were overweight or obese. The major finding of the present study is that 12 weeks of exercise training alone can improve insulin secretion in addition to the improvement in insulin sensitivity and decrease in body mass, suggesting that this intervention is effective to induce glucose homeostasis in adolescent obesity. Although significant changes in BW and BMI in the overweight/obese adolescents were about 5.3 and 4.4%, respectively, following exercise training, their BFP and BFM values declined about 28.2 and 30.3%, respectively, suggesting that the loss in body mass was predominantly composed of fat. Furthermore, the insulin sensitivity of the overweight/obese group significantly increased following exercise training even in patients with abnormal glucose tolerance at baseline (i.e., the IGT group).

Impaired insulin sensitivity, which may appear prior to glucose dysregulation in adolescents [25], is a major component of obesity and its co-morbid diseases, such as T2DM and cardiovascular disease (CVD). However, studies evaluating the impact of exercise on insulin sensitivity in children and adolescents with obesity have been inconsistent. In prepubertal girls with obesity, both insulin sensitivity and intra-abdominal adipose tissue remained unchanged following a strength-training program [26]. In another study, strength exercise did not change peripheral insulin sensitivity but improved the muscle mass and hepatic insulin sensitivity in youth with obesity [27]. However, other studies showed that physical training improves insulin sensitivity despite no change in fat mass [28, 29]. In the present study, most of the participants in the overweight/obese group showed significant reductions in body mass and fat mass, and their FSI and HOMA-IR were reduced by about 38, and 39%, respectively. In contrast, Abrams et al. [30] reported that a decrease in BMI of 8% was required for improvements in insulin sensitivity in adolescents participating in a 4-month behavioral weight loss trial.

The conflicting data regarding the effects of exercise on anthropomorphic measures and insulin sensitivity are likely due to differences in the exercise modality. For example, postpubertal adolescents participating in a combined aerobic and resistance training program experienced greater losses of body fat and WC [31]. Furthermore, in a randomized controlled trial comparing resistance versus aerobic exercise in adolescent boys with obesity, improvements in insulin sensitivity were observed with resistance exercise alone [17].

Subjects with obesity frequently have basal hyperinsulinemia and an exaggerated response to stimulation by a test meal or glucose attributed to increased insulin secretion and reduced insulin clearance [32, 33]. In the present study, both the FSI and total insulin response during OGTT decreased significantly after the exercise training, which is in agreement with previous studies showing improved fasting and stimulatory insulin response after weight loss [3436].

Previous work has highlighted the beneficial effects of lifestyle interventions on insulin secretion and β-cell function in adults with obesity [1113]; however, few adolescent-based studies have been conducted to date [17]. In addition, a defect in first-phase insulin response is an early event in the development of T2DM in youth [6, 7], and decreased β-cell function in Latino adolescents with overweight has been noted after Tanner 3 [37]. In the present study, we found significant increase in the DI after the 12-week training, suggesting an improvement in β-cell function. This finding is promising because it suggests that impairment of first-phase insulin secretion is reversible at least in part. This notion is further supported by the OGTT results, which showed significant decreases in both glucose and insulin levels at all the time points analyzed.

It has been previously reported that both strength training and aerobic exercise improve hepatic insulin sensitivity [26, 27], and our HOMA-IR results further support this notion. However, HOMA-IR and OGTT are rough indices of whole body insulin sensitivity and hepatic insulin sensitivity. Matsuda et al. [38] described a simple, novel estimate of whole body and hepatic insulin sensitivity using indices derived from the OGTT, which correlated well with values obtained with the euglycemic insulin clamp. Thus, further studies will examine whether the impact of this particular exercise program was specific to improving hepatic insulin sensitivity.

The present study is limited in that it included only Taiwanese male adolescents. In addition, the sample sizes of both groups were relatively small, and the OGTT was only performed in the participants with obesity. Therefore, the result may not be applicable to female adolescents or populations of different ethnicity, which is particularly relevant given the ethnic differences in first-phase insulin secretion observed among peripubertal children [39]. Additional studies are also necessary to examine if a longer exercise intervention would provide further improvements in insulin sensitivity and anthropomorphic measures. Furthermore, measures of exercise intensity and energy expenditure (i.e., heart rate, accelerometer or pedometer measures, or measures of perceived exertion) were not determined. Finally, although the participants were encouraged to decrease their food intake during the study period, measures of food intake or food records were not maintained.


In conclusion, a 12-week exercise training program significantly improved the insulin sensitivity and insulin secretion in overweight or obese male adolescents even in those with impaired glucose tolerance. These improvements were associated with reductions in both fasting and 2-h glucose levels. Thus, exercise training may represent a critical intervention for preventing not only diabetes, but also future CVD. Further studies with larger sample sizes and longer training periods are warranted.



Analysis of variance


Area under the curve


Body fat mass


Body fat percentage


Body mass index


Cardiovascular disease


Disposition index


Fasting plasma glucose


Fasting serum insulin


Homeostasis model assessment of insulin resistance


Impaired glucose tolerance




Normal glucose tolerance


Oral glucose tolerance test


Type 2 diabetes mellitus


Waist circumference





This study was partly supported by research grant from Taipei Veterans General Hospital (V101-C-207).

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

KCS designed and performed experiments, analysed data and wrote the main paper; CFK designed the analytical tools and explained the results. All authors discussed the results and implications and commented on the manuscript at all stages. Both authors read and approved the final manuscript.

Ethics approval and consent to participate

The Institution Review Board of the Taipei Veterans General Hospital approved this study. Written informed consent was obtained after explaining the study procedures and protocol to the participants and their parents or legal guardians.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Division of Endocrinology and Metabolism, Department of Medicine, Cheng-Hsin General Hospital, Taipei, Taiwan
Division of Endocrinology and Metabolism, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan
Division of Endocrinology and Metabolism, Department of Medicine, Taipei-Veteran General Hospital, Taipei, Taiwan


  1. Li S, Chen W, Srinivasan SR, Xu J, Berenson GS. Relation of childhood obesity/cardiometabolic phenotypes to adult cardiometabolic profile: the Bogalusa Heart Study. Am J Epidemiol. 2012;176:S142–9.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011–2012. J Am Med Assoc. 2014;311(8):806–14.View ArticleGoogle Scholar
  3. Casavalle PL, Lifshitz F, Romano LS, Pandolfo M, Caamaño A, Boyer PM, et al. Prevalence of dyslipidemia and metabolic syndrome risk factor in overweight and obese children. Pediatr Endocrinol Rev. 2014;12(2):213–23.PubMedGoogle Scholar
  4. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Investig. 1999;104(6):787–94.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Festa A, Williams K, D’Agostino R Jr, Wagenknecht LE, Haffner SM. The natural course of beta-cell function in nondiabetic and diabetic individuals: the Insulin Resistance Atherosclerosis Study. Diabetes. 2006;55(4):1114–20.View ArticlePubMedGoogle Scholar
  6. Saad R, Gungor N, Arslanian S. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates. Pediatr Diabetes. 2005;6(2):95–9.View ArticlePubMedGoogle Scholar
  7. Kelly LA, Lane CJ, Weigensberg MJ, Koebnick C, Roberts CK, Davis JN, et al. Parental history and risk of type 2 diabetes in overweight Latino adolescents: a longitudinal analysis. Diabetes Care. 2007;30(10):2700–5.View ArticlePubMedGoogle Scholar
  8. Bruce CR, Kriketos AD, Cooney GJ, Hawley JA. Disassociation of muscle triglyceride content and insulin sensitiity after exercise training in patients with type 2 diabetes. Diabetologia. 2004;47(1):23–30.View ArticlePubMedGoogle Scholar
  9. O’Leary VB, Marchetti CM, Krishnan RK, Stetzer BP, Gonzalez F, Kirwan JP. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol. 2006;100(5):1584–9.View ArticlePubMedGoogle Scholar
  10. Jeon CY, Lokken RP, Hu FB, van Dam RM. Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care. 2007;30(3):744–52.View ArticlePubMedGoogle Scholar
  11. Utzschneider KM, Carr DB, Barsness SM, Kahn SE, Schwartz RS. Diet-induced weight loss is associated with an improvement in beta-cell function in older men. J Clin Endocrinol Metab. 2004;89(6):2704–10.View ArticlePubMedGoogle Scholar
  12. Bloem CJ, Chang AM. Short-term exercise improves beta-cell function and insulin rssistance in older people with impaired glucose tolerance. J Clin Endocrinol Metab. 2008;93(2):387–92.View ArticlePubMedGoogle Scholar
  13. Slentz CA, Tanner CJ, Bateman LA, Durheim MT, Huffman KM, Houmard JA, et al. Effects of exercise training intensity on pancreatic beta-cell function. Diabetes Care. 2009;32(10):1807–11.View ArticlePubMedPubMed CentralGoogle Scholar
  14. García-Hermoso A, Saavedra JM, Escalante Y, Sánchez-López M, Martínez-Vizcaíno V. Endocrinology and Adolescence: aerobic exercise reduces insulin resistance markers in obese youth: a meta-analysis of randomized controlled trials. Eur J Endocrinol. 2014;171(4):R163–71.View ArticlePubMedGoogle Scholar
  15. Huang CJ, Kwok CF, Chou CH, Chou YC, Ho LT, Shih KC. The effect of exercise on lipid profiles and inflammatory markers in lean male adolescents: a prospective interventional study. J Investig Med. 2015;63(1):29–34.View ArticlePubMedGoogle Scholar
  16. Shih KC, Janckila AJ, Kwok CF, Ho LT, Chou YC, Chao TY. Effects of exercise on insulin sensitivity, inflammatory cytokines, and serum tartrate-resistant acid phosphatase 5a in obese Chinese male adolescents. Metabolism. 2010;59(1):144–51.View ArticlePubMedGoogle Scholar
  17. Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes. 2012;61(11):2787–95.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Chen W, Lin CC, Peng CT, Li CI, Wu HC, Chiang J, et al. Approaching healthy body mass index norms for children and adolescents from health-related physical fitness. Obes Rev. 2002;3(3):225–32.View ArticlePubMedGoogle Scholar
  19. Marshall WA, Tanner JM. Growth and physiological development during adolescence. Ann Rev Med. 1968;19:283–300.View ArticlePubMedGoogle Scholar
  20. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33:S62–9.View ArticlePubMed CentralGoogle Scholar
  21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.View ArticlePubMedGoogle Scholar
  22. Gastaldelli A, Ferrannini E, Miyazaki Y, Matsuda M, DeFronzo RA, San Antonio metabolism study. Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study. Diabetologia. 2004;47(1):31–9.View ArticlePubMedGoogle Scholar
  23. DeFronzo RA, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, et al. Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. Diabetologia. 2010;53(3):435–45.View ArticlePubMedGoogle Scholar
  24. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE, American Diabetes Association GENNID Study Group. Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes. 2002;51(7):2170–8.View ArticlePubMedGoogle Scholar
  25. Giannini C, Weiss R, Cali A, Bonadonna R, Santoro N, Pierpont B, et al. Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study. Diabetes. 2012;61(3):606–14.View ArticlePubMedPubMed CentralGoogle Scholar
  26. van der Heijden GJ, Toffolo G, Manesso E, Sauer PJ, Sunehag AL. Aerobic exercise increases peripheral and hepatic insulin sensitivity in sedentary adolescents. J Clin Endocrinol Metab. 2009;94(11):4292–9.View ArticlePubMedPubMed CentralGoogle Scholar
  27. van der Heijden GJ, Wang ZJ, Chu Z, Toffolo G, Manesso E, Sauer PJ, et al. Strength exercise improves muscle mass and hepatic insulin sensitivity in obese youth. Med Sci Sports Exerc. 2010;42(11):1973–80.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Nassis GP, Papantakou K, Skenderi K, Triandafillopoulou M, Kavouras SA, Yannakoulia M, et al. Aerobic exercise training improves insulin sensitivity without changes in body weight, body fat, adiponectin, and inflammatory markers in overweight and obese girls. Metabolism. 2005;54(11):1472–9.View ArticlePubMedGoogle Scholar
  29. Shaibi GQ, Cruz ML, Ball GD, Weigensberg MJ, Salem GJ, Crespo NC, et al. Effects of resistance training on insulin sensitivity in overweight Latino adolescent males. Med Sci Sports Exerc. 2006;38(7):1208–15.View ArticlePubMedGoogle Scholar
  30. Abrams P, Levitt Katz LE, Moore RH, Xanthopoulos MS, Bishop-Gilyard CT, Wadden TA, et al. Threshold for improvement in insulin sensitivity with adolescent weight loss. J Pediatr. 2013;163(3):785–90.View ArticlePubMedGoogle Scholar
  31. Sigal RJ, Alberga AS, Goldfield GS, Prud’homme D, Hadjiyannakis S, Gougeon R, et al. Effects of aerobic training, resistance training, or both on percentage body fat and cardiometabolic risk markers in obese adolescents: the healthy eating aerobic and resistance training in youth randomized clinical trial. JAMA Pediatr. 2014;168(11):1006–14.View ArticlePubMedGoogle Scholar
  32. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab. 1993;76(1):44–8.PubMedGoogle Scholar
  33. Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Investig. 1997;100(5):1166–73.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Muscelli E, Camastra S, Catalano C, Galvan AQ, Ciociaro D, Baldi S, et al. Metabolic and cardiovascular assessment in moderate obesity: effect of weight loss. J Clin Endocrinol Metab. 1997;82(9):2937–43.View ArticlePubMedGoogle Scholar
  35. Tuominen JA, Ebeling P, Koivisto VA. Exercise increases insulin clearance in healthy man and insulin-dependent diabetes mellitus patients. Clin Physiol. 1997;17(1):19–30.View ArticlePubMedGoogle Scholar
  36. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, et al. Mechanisms of beta-cell death in type 2 diabetes. Diabetes. 2005;54:S108–13.View ArticlePubMedGoogle Scholar
  37. Kelly LA, Lane CJ, Weigensberg MJ, Toledo-Corral CM, Goran MI. Pubertal changes of insulin sensitivity, acute insulin response, and β-cell function in overweight Latino youth. J Pediatr. 2011;158(3):442–6.View ArticlePubMedPubMed CentralGoogle Scholar
  38. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462–70.View ArticlePubMedGoogle Scholar
  39. Casazza K, Phadke RP, Fernandez JR, Watanabe RM, Goran MI, Gower BA. Obesity attenuates the contribution of African admixture to the insulin secretory profile in peripubertal children: a longitudinal analysis. Obesity. 2009;17(7):1318–25.PubMedPubMed CentralGoogle Scholar


© The Author(s). 2018